Adverse events Study reports · adults with Major Depressive Disorder
It is very uncertain whether n3PUFAs changes adverse eventsStudy reports compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events rate‐Diarrhea · Crohn's disease patients in remission
The intervention probably leads to higher adverse events rate‐Diarrhea (moderate certainty).
1 finding from 1 review
Intervention not reported
Maternal serious adverse events · pregnant women
The intervention showed no clear difference in maternal serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events for neonate/infant · pregnant women and their babies
The intervention may leads to lower serious adverse events for neonate/infant (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events rate‐ Upper GI (nausea, vomiting, halitosis, heartburn, dyspepsia, dysgeusia and bloating) · Crohn's disease patients in remission
The intervention probably leads to higher adverse events rate‐ Upper GI (nausea, vomiting, halitosis,… (moderate certainty).
1 finding from 1 review
Serious adverse events "Defined as events that result in death, hospitalization, prolongation of hospitalization, or are life threatening (based on the judgment of the study physician)" (Quinn 2010) · Apathy in people with mild‐to‐moderate Alzheimer's disease
Omega‐3 PUFA supplements showed no clear difference in serious adverse events "Defined as events that result in death,… compared with placebo (high certainty).
1 finding from 1 review